Steven John Thompson, MD | |
5200 Fairview Blvd, Wyoming, MN 55092-8013 | |
(651) 982-7000 | |
Not Available |
Full Name | Steven John Thompson |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 28 Years |
Location | 5200 Fairview Blvd, Wyoming, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124046636 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 39880 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Fairview Lakes Health Services | Wyoming, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Fairview Express Care | 3375645179 | 1523 |
Fairview Clinics | 7113830142 | 658 |
News Archive
The Multiple Sclerosis Association of America is pleased to announce that the newly published About MS booklet is now available as both a printed and online publication.
Genzyme Corporation today reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB did not show a significant improvement in phosphate lowering compared to Genzyme's Renvela® (sevelamer carbonate).
In a new SLAS Technology auto-commentary, two authors of an article recently published in Nature Biomedical Engineering ("Abnormal Scar Identification with Spherical Nucleic Acid Technology" – www.nature.com/articles/s41551-018-0218-x) share more insight into their unique method for skin disease diagnosis using NanoFlare nanotechnology.
Scientists on the cutting edge of biomedical research know that research is a process - a combination of successes and failures that inform the next step forward. However, for some researchers at The Ohio State University progress means taking a step back. Supported by the Ohio State University Center for Clinical and Translational Science (CCTS), these scientists are using failed and forgotten research to uncover future treatments for major health conditions as diverse as oral cancer and stroke.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that it recently was advised that its Suzhou Erye Pharmaceutical subsidiary ("Erye") received approval from the State Food and Drug Administration (SFDA) in China to manufacture solvent crystallization sterile penicillin and freeze dried raw sterile penicillin at their new facility which provides 50% and 100% greater manufacturing capacity, respectively, than its existing facility. Historically, these two lines have accounted for approximately 20% of Erye's sales.
› Verified 1 days ago
Entity Name | Fairview Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
The Multiple Sclerosis Association of America is pleased to announce that the newly published About MS booklet is now available as both a printed and online publication.
Genzyme Corporation today reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB did not show a significant improvement in phosphate lowering compared to Genzyme's Renvela® (sevelamer carbonate).
In a new SLAS Technology auto-commentary, two authors of an article recently published in Nature Biomedical Engineering ("Abnormal Scar Identification with Spherical Nucleic Acid Technology" – www.nature.com/articles/s41551-018-0218-x) share more insight into their unique method for skin disease diagnosis using NanoFlare nanotechnology.
Scientists on the cutting edge of biomedical research know that research is a process - a combination of successes and failures that inform the next step forward. However, for some researchers at The Ohio State University progress means taking a step back. Supported by the Ohio State University Center for Clinical and Translational Science (CCTS), these scientists are using failed and forgotten research to uncover future treatments for major health conditions as diverse as oral cancer and stroke.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that it recently was advised that its Suzhou Erye Pharmaceutical subsidiary ("Erye") received approval from the State Food and Drug Administration (SFDA) in China to manufacture solvent crystallization sterile penicillin and freeze dried raw sterile penicillin at their new facility which provides 50% and 100% greater manufacturing capacity, respectively, than its existing facility. Historically, these two lines have accounted for approximately 20% of Erye's sales.
› Verified 1 days ago
Entity Name | Fairview Clinics |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
The Multiple Sclerosis Association of America is pleased to announce that the newly published About MS booklet is now available as both a printed and online publication.
Genzyme Corporation today reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB did not show a significant improvement in phosphate lowering compared to Genzyme's Renvela® (sevelamer carbonate).
In a new SLAS Technology auto-commentary, two authors of an article recently published in Nature Biomedical Engineering ("Abnormal Scar Identification with Spherical Nucleic Acid Technology" – www.nature.com/articles/s41551-018-0218-x) share more insight into their unique method for skin disease diagnosis using NanoFlare nanotechnology.
Scientists on the cutting edge of biomedical research know that research is a process - a combination of successes and failures that inform the next step forward. However, for some researchers at The Ohio State University progress means taking a step back. Supported by the Ohio State University Center for Clinical and Translational Science (CCTS), these scientists are using failed and forgotten research to uncover future treatments for major health conditions as diverse as oral cancer and stroke.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that it recently was advised that its Suzhou Erye Pharmaceutical subsidiary ("Erye") received approval from the State Food and Drug Administration (SFDA) in China to manufacture solvent crystallization sterile penicillin and freeze dried raw sterile penicillin at their new facility which provides 50% and 100% greater manufacturing capacity, respectively, than its existing facility. Historically, these two lines have accounted for approximately 20% of Erye's sales.
› Verified 1 days ago
Entity Name | Fairview Express Care |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
The Multiple Sclerosis Association of America is pleased to announce that the newly published About MS booklet is now available as both a printed and online publication.
Genzyme Corporation today reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB did not show a significant improvement in phosphate lowering compared to Genzyme's Renvela® (sevelamer carbonate).
In a new SLAS Technology auto-commentary, two authors of an article recently published in Nature Biomedical Engineering ("Abnormal Scar Identification with Spherical Nucleic Acid Technology" – www.nature.com/articles/s41551-018-0218-x) share more insight into their unique method for skin disease diagnosis using NanoFlare nanotechnology.
Scientists on the cutting edge of biomedical research know that research is a process - a combination of successes and failures that inform the next step forward. However, for some researchers at The Ohio State University progress means taking a step back. Supported by the Ohio State University Center for Clinical and Translational Science (CCTS), these scientists are using failed and forgotten research to uncover future treatments for major health conditions as diverse as oral cancer and stroke.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that it recently was advised that its Suzhou Erye Pharmaceutical subsidiary ("Erye") received approval from the State Food and Drug Administration (SFDA) in China to manufacture solvent crystallization sterile penicillin and freeze dried raw sterile penicillin at their new facility which provides 50% and 100% greater manufacturing capacity, respectively, than its existing facility. Historically, these two lines have accounted for approximately 20% of Erye's sales.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Steven John Thompson, MD 5200 Fairview Blvd, Wyoming, MN 55092-8013 Ph: () - | Steven John Thompson, MD 5200 Fairview Blvd, Wyoming, MN 55092-8013 Ph: (651) 982-7000 |
News Archive
The Multiple Sclerosis Association of America is pleased to announce that the newly published About MS booklet is now available as both a printed and online publication.
Genzyme Corporation today reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB did not show a significant improvement in phosphate lowering compared to Genzyme's Renvela® (sevelamer carbonate).
In a new SLAS Technology auto-commentary, two authors of an article recently published in Nature Biomedical Engineering ("Abnormal Scar Identification with Spherical Nucleic Acid Technology" – www.nature.com/articles/s41551-018-0218-x) share more insight into their unique method for skin disease diagnosis using NanoFlare nanotechnology.
Scientists on the cutting edge of biomedical research know that research is a process - a combination of successes and failures that inform the next step forward. However, for some researchers at The Ohio State University progress means taking a step back. Supported by the Ohio State University Center for Clinical and Translational Science (CCTS), these scientists are using failed and forgotten research to uncover future treatments for major health conditions as diverse as oral cancer and stroke.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that it recently was advised that its Suzhou Erye Pharmaceutical subsidiary ("Erye") received approval from the State Food and Drug Administration (SFDA) in China to manufacture solvent crystallization sterile penicillin and freeze dried raw sterile penicillin at their new facility which provides 50% and 100% greater manufacturing capacity, respectively, than its existing facility. Historically, these two lines have accounted for approximately 20% of Erye's sales.
› Verified 1 days ago
Dean E Krats, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7000 | |
David J Tosteson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7000 | |
Anita Bajpai, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7000 | |
John P Eikens, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7000 | |
Kevin Ronneberg, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7000 | |
Deborah K Strand, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5200 Fairview Blvd, Wyoming, MN 55092 Phone: 651-982-7000 |